Falcon Genomics, Inc.

An eye on functional genomics as a tool for cancer diagnostics and therapeutics.
Home
News
The Cancer BioChip System
Officers
Presentations
Founders
Contact Us
CBCS services
Careers
Gene Expression Profiling

Mission

The goal of Falcon Genomics, Inc. is to provide cutting edge technologies for the accurate diagnosis of cancer patients and the personalized formulation of therapeutic strategies.

Technology Platform
Falcon Genomics' patented technology platform, the Cancer BioChip System (CBCS™) identifies, in a high-throughput three-dimensional fashion, compounds that are required for anchorage-independent growth of patient cells, a hallmark of cellular transformation. Potential compounds include silencing RNA libraries that contain inhibitors for every gene in the human genome.

Technology Applications

The CBCS™ can be initially used for high-throughput cancer therapeutic target identification and validation. Through future clinical trials, the CBCS™ can be developed into a diagnostic tool that can be used to guide patient-specific cancer therapies.

Recent News

December 1, 2011

Falcon Genomics, Inc. receives notice of allowance for its US Patent Application # 11/772,411.

October 6-7, 2011

Falcon Genomics, Inc. reports on the screening power of its Test Cancer BioChip in a poster titled: "Use of the Cancer Biochip System as a Tool for Identifying Therapeutic Targets in Personalizing Breast Cancer Treatment" at the Academic Screening Workshop, Bridgewater, NJ.

June 28, 2011

Dr. Rula Abbud-Antaki presents Falcon Genomics' Company Presentation at BIO 2011, Washington, DC

Falcon Genomics, Inc. announces opening of its gene expression profiling service.



 Clients

Pharmaceutical companies and research insitutions seeking a rapid and efficient platform for the identification of cancer targets in a setting that mimics the in-vivo milieu.

 

Please contact Dr. Rula Abbud-Antaki for further information: rabbud@falcongenomics.com

Address:

160 North Craig Street, Suite 222, Pittsburgh, PA 15213, Phone: 412-802-6236, Fax: 412-802-7048, e-mail: falcongenomics@verizon.net